Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
Noemí Esteras, Andrey Y. Abramov
Cells (2020) Vol. 9, Iss. 9, pp. 2135-2135
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Role of Cholinergic Signaling in Alzheimer’s Disease
Zhi-Ru Chen, Jiabao Huang, Shu‐Long Yang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1816-1816
Open Access | Times Cited: 384
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 134-157
Closed Access | Times Cited: 128
The mitochondrial permeability transition: Recent progress and open questions
Paolo Bernardi, Michela Carraro, Giovanna Lippe
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 7051-7074
Open Access | Times Cited: 108
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 104
Interaction of Mitochondrial Calcium and ROS in Neurodegeneration
Artyom Y. Baev, Andrey Y. Vinokurov, Irina N. Novikova, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 706-706
Open Access | Times Cited: 98
Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond
Noemí Esteras, Andrey Y. Abramov
Free Radical Biology and Medicine (2022) Vol. 189, pp. 136-153
Open Access | Times Cited: 94
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
Role of Calcium Homeostasis in Alzheimer’s Disease
Mengqian Ge, Jinghui Zhang, Simiao Chen, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 487-498
Open Access | Times Cited: 74
Mitochondrial calcium cycling in neuronal function and neurodegeneration
Grant C. Walters, Yuriy M. Usachev
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 45
Endoplasmic reticulum stress and the unfolded protein response: emerging regulators in progression of traumatic brain injury
Yayi Yang, Dengfeng Lu, Menghan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 28
Understanding of Alzheimer's Disease Pathophysiology for Therapeutic Implications of Natural Products as Neuroprotective Agents
Sneh Prabha, Arunabh Choudhury, Asimul Islam, et al.
Ageing Research Reviews (2025), pp. 102680-102680
Closed Access | Times Cited: 2
Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress
Anamaria Jurcău
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11847-11847
Open Access | Times Cited: 84
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Nicole Rummel, D. Allan Butterfield
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 16-18, pp. 1289-1305
Open Access | Times Cited: 71
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Anamaria Jurcău
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1432-1432
Open Access | Times Cited: 61
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Protein aggregation: Consequences, mechanism, characterization and inhibitory strategies
Nabeela Majid, Rizwan Hasan Khan
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125123-125123
Closed Access | Times Cited: 24
Mitochondrial Permeability Transition, Cell Death and Neurodegeneration
Artyom Y. Baev, Andrey Y. Vinokurov, Elena Potapova, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 648-648
Open Access | Times Cited: 15
MCU complex: Exploring emerging targets and mechanisms of mitochondrial physiology and pathology
Jin Wang, Jinyong Jiang, Haoliang Hu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 10
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
Angie K. Torres, Claudia Jara, Han S. Park-Kang, et al.
Journal of Alzheimer s Disease (2021) Vol. 84, Iss. 4, pp. 1391-1414
Closed Access | Times Cited: 51
Mitochondrial ROS control neuronal excitability and cell fate in frontotemporal dementia
Noemí Esteras, Olga Kopach, Marta Maiolino, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 2, pp. 318-338
Open Access | Times Cited: 49
Sources and triggers of oxidative damage in neurodegeneration
Plamena R. Angelova
Free Radical Biology and Medicine (2021) Vol. 173, pp. 52-63
Open Access | Times Cited: 48
The Antioxidant Activity of Limonene Counteracts Neurotoxicity Triggered byAβ1-42 Oligomers in Primary Cortical Neurons
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 937-937
Open Access | Times Cited: 47
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
Gurvir S. Virdi, Minee L. Choi, James R. Evans, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation
Roberto Iorio, Giuseppe Celenza, Sabrina Petricca
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1199-1199
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top